Table 2. Medication Adherence Estimates from Quantile Regression Models (Adjusted)*.
| 25th | 50th | 75th | |||||
|---|---|---|---|---|---|---|---|
| Adjusted | p-value | Adjusted | p-value | Adjusted | p-value | ||
|
Adherence to Anti-diabetic Medications (N = 112,897 observations for
43,445 patients) |
Age <35 | 22.9% | < .001 | 47.3% | < .001 | 75.3% | < .001 |
| Age 35-49 | 36.6% | < .001 | 65.6% | < .001 | 86.9% | < .001 | |
| Age 50-64 | 52.6% | Ref | 77.6% | Ref | 91.6% | Ref | |
| Age 65+ | 55.5% | < .001 | 79.3% | < .001 | 92.3% | < .001 | |
| Female | 49.0% | < .001 | 73.9% | < .001 | 89.8% | < .001 | |
| Male | 51.0% | Ref | 76.1% | Ref | 91.0% | Ref | |
| Honolulu | 51.8% | < .001 | 76.8% | < .001 | 91.0% | .02 | |
| Other regions | 48.9% | Ref | 74.3% | Ref | 90.1% | Ref | |
| High morbidity | 50.6% | < .001 | 75.7% | < .001 | 90.7% | < .001 | |
| Low morbidity | 49.5% | Ref | 74.8% | Ref | 90.3% | Ref | |
| Coronary artery disease | 53.1% | .4 | 77.3% | 1.0 | 91.5% | .4 | |
| Congestive heart failure | 50.4% | < .001 | 74.9% | < .001 | 90.6% | < .001 | |
| White | 56.9% | Ref | 79.6% | Ref | 92.4% | Ref | |
| Japanese | 57.6% | .5 | 81.2% | < .001 | 92.9% | .07 | |
| Chinese | 56.0% | .2 | 80.0% | 1.0 | 92.4% | 1.0 | |
| Filipino | 50.7% | < .001 | 76.9% | < .001 | 90.8% | .002 | |
| Native Hawaiian | 50.4% | < .001 | 74.1% | < .001 | 90.2% | < .001 | |
| Other Pacific Islander | 42.0% | < .001 | 69.2% | < .001 | 90.2% | .001 | |
| Other race | 55.7% | .2 | 78.3% | .1 | 91.8% | .2 | |
|
| |||||||
|
Adherence to Lipid-Lowering Medications (N = 82,477 observations
for 30,801 patients) |
Age <35 | 18.1% | < .001 | 38.8% | < .001 | 69.4% | < .001 |
| Age 35-49 | 31.5% | < .001 | 60.1% | < .001 | 83.4% | < .001 | |
| Age 50-64 | 46.5% | Ref | 72.9% | Ref | 88.3% | Ref | |
| Age 65+ | 50.1% | < .001 | 75.1% | < .001 | 89.8% | < .001 | |
| Female | 42.3% | < .001 | 68.1% | < .001 | 86.4% | < .001 | |
| Male | 45.9% | Ref | 71.8% | Ref | 88.1% | Ref | |
| Honolulu | 46.2% | < .001 | 72.2% | < .001 | 88.3% | < .001 | |
| Other regions | 43.2% | Ref | 69.1% | Ref | 86.9% | Ref | |
| High morbidity | 44.9% | .1 | 70.2% | .3 | 87.3% | .7 | |
| Low morbidity | 43.9% | Ref | 70.0% | Ref | 87.3% | Ref | |
| Coronary artery disease | 48.3% | .02 | 73.6% | < .001 | 89.0% | .001 | |
| Congestive heart failure | 45.7% | .005 | 70.8% | .003 | 88.1% | .03 | |
| White | 53.7% | Ref | 76.9% | Ref | 89.7% | Ref | |
| Japanese | 54.4% | .5 | 77.9% | .09 | 90.5% | .008 | |
| Chinese | 51.1% | .004 | 75.8% | .046 | 89.9% | .7 | |
| Filipino | 42.1% | < .001 | 69.5% | < .001 | 87.4% | < .001 | |
| Native Hawaiian | 43.1% | < .001 | 68.0% | < .001 | 86.4% | < .001 | |
| Other Pacific Islander | 30.8% | < .001 | 57.0% | < .001 | 82.6% | .005 | |
| Other race | 47.1% | < .001 | 72.2% | < .001 | 88.4% | .004 | |
|
| |||||||
|
Adherence to Anti-hypertensive Medications (N =87,969 observations
for 33,443 patients) |
Age <35 | 24.2% | < .001 | 48.2% | < .001 | 75.7% | < .001 |
| Age 35-49 | 43.0% | < .001 | 71.6% | < .001 | 89.2% | < .001 | |
| Age 50-64 | 59.7% | Ref | 82.0% | < .001 | 92.9% | < .001 | |
| Age 65+ | 64.3% | < .001 | 84.8% | < .001 | 94.5% | < .001 | |
| Female | 56.4% | .002 | 79.3% | < .001 | 91.8% | < .001 | |
| Male | 57.9% | Ref | 80.6% | Ref | 92.6% | Ref | |
| Honolulu | 58.7% | .06 | 81.1% | .008 | 92.7% | .04 | |
| Other regions | 56.5% | Ref | 79.4% | Ref | 92.0% | Ref | |
| High morbidity | 58.7% | .01 | 81.0% | < .001 | 92.9% | < .001 | |
| Low morbidity | 56.5% | Ref | 79.5% | Ref | 91.9% | Ref | |
| Coronary Artery Disease | 64.0% | < .001 | 84.5% | < .001 | 94.5% | < .001 | |
| Congestive Heart Failure | 63.7% | < .001 | 84.3% | < .001 | 94.8% | < .001 | |
| White | 64.9% | Ref | 84.1% | Ref | 93.8% | Ref | |
| Japanese | 64.6% | .7 | 84.7% | .09 | 94.3% | .008 | |
| Chinese | 62.8% | .006 | 83.5% | .1 | 93.8% | .4 | |
| Filipino | 59.2% | < .001 | 82.0% | .006 | 93.0% | .009 | |
| Native Hawaiian | 57.7% | < .001 | 79.5% | < .001 | 92.2% | < .001 | |
| Other Pacific Islander | 46.9% | .001 | 73.8% | < .001 | 89.5% | .01 | |
| Other Race | 62.3% | .02 | 83.1% | .01 | 93.7% | .3 | |
Note.
*
Adjusted for all other variables in the model and year (not shown).